Product Information

SYMBICORT 160-4.5 MCG INHALER is a brand product labeled by AstraZeneca Pharmaceuticals LP, priced at $22.0170 per GM under NDC 00186037020. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Jul 21, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SYMBICORT 160-4.5 MCG INHALER

Budesonide and Formoterol Fumarate Dihydrate
$22.0170per GM

Strength

160; 4.5 ug/1; ug/1

NDC

00186037020

Classification

Brand

Dosage Form

AEROSOL

Route

RESPIRATORY (INHALATION)

Effective Date

8/19/2026

Approval Type

New Drug (NDA)

FDA Application

NDA021929

FDA Approved

7/21/2006

TE Code

AB

On Market Since

5/29/2007

Pharmacological Classes

Adrenergic beta2-Agonists
Corticosteroid Hormone Receptor Agonists
Corticosteroid
beta2-Adrenergic Agonist

Price Statistics

The NADAC for SYMBICORT 160-4.5 MCG INHALER has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 2.8%. The table below summarizes its recorded NADAC range and movement.

Current price$22.0170 per GM
All-time high$36.7615 (Oct 11, 2023)
All-time low$22.0170 (Aug 19, 2026)
52-week high$22.0346
52-week low$22.0170
Median price$29.1090
Average price$29.2602
Largest weekly change-40.0% (Jan 10, 2024)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

-0.0%

1M

-0.0%

3M

-0.0%

6M

-0.0%

1Y

-0.1%

3Y

-40.1%

5Y

-37.0%

All

-2.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 21% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 21%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of SYMBICORT 160-4.5 MCG INHALER?

The current National Average Drug Acquisition Cost (NADAC) for SYMBICORT 160-4.5 MCG INHALER, manufactured by AstraZeneca Pharmaceuticals LP, is $22.0170 per GM (NDC 00186037020), effective Aug 19, 2026.

How has the price of SYMBICORT 160-4.5 MCG INHALER changed over time?

Over the history we have for it, the NADAC for SYMBICORT 160-4.5 MCG INHALER has declined 2.8%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for SYMBICORT 160-4.5 MCG INHALER?

Since Nov 28, 2013, the NADAC for SYMBICORT 160-4.5 MCG INHALER has ranged from a low of $22.0170 (Aug 19, 2026) to a high of $36.7615 (Oct 11, 2023), with a median of $29.1090 per GM.

Are there cheaper alternatives to SYMBICORT 160-4.5 MCG INHALER?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUDESONIDE-FORMOTEROL 160-4.5, is $17.4690 per GM — about 21% below SYMBICORT 160-4.5 MCG INHALER.

Who manufactures SYMBICORT 160-4.5 MCG INHALER?

SYMBICORT 160-4.5 MCG INHALER (NDC 00186037020) is labeled by AstraZeneca Pharmaceuticals LP, and CMS classifies it as a brand product.